Castleview Partners, LLC / BMY
Castleview Partners, LLC’s Bristol-Myers Squibb Co Position
Does Castleview Partners, LLC own Bristol-Myers Squibb Co (BMY)? Yes — 74.0K shares worth $4M (+2.30% of its 13F portfolio) as of Q1 2026, down from 85.5K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
74.0K
% of Portfolio
+2.30%
Quarters Held
19
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 74.0K | $4M | +2.30% |
| Q4 2025 | 85.5K | $5M | +2.29% |
| Q3 2025 | 74.0K | $3M | +1.81% |
| Q2 2025 | 69.5K | $3M | +2.07% |
| Q1 2025 | 67.9K | $4M | +2.80% |
| Q4 2024 | 55.2K | $3M | +1.69% |
| Q3 2024 | 49.4K | $3M | +1.48% |
| Q2 2024 | 5.7K | $237,178 | +0.13% |
| Q1 2024 | 3.7K | $199,631 | +0.11% |
| Q4 2023 | 2.5K | $127,362 | +0.09% |
| Q3 2023 | 2.1K | $119,561 | +0.11% |
| Q2 2023 | 2.1K | $135,574 | +0.12% |
| Q1 2023 | 3.5K | $243,621 | +0.22% |
| Q4 2022 | 3.4K | $243,547 | +0.24% |
| Q3 2022 | 2.9K | $203,000 | +0.19% |
| Q2 2022 | 4 | $2M | 0.00% |
| Q1 2022 | 3.3K | $239,000 | +0.15% |
| Q4 2021 | 254.1K | $4M | +0.03% |
| Q2 2021 | 2.7K | $178,000 | +0.08% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Castleview Partners, LLC’s full portfolio or all institutional holders of BMY.